Lamivudine and Zidovudine (Rebel Distributors Corp)
Welcome to the PulseAid listing for the Lamivudine and Zidovudine drug offered from Rebel Distributors Corp. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rebel Distributors Corp |
NON-PROPRIETARY NAME: | Lamivudine and Zidovudine |
SUBSTANCE NAME: | LAMIVUDINE; ZIDOVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-27 |
END MARKETING DATE: | 0000-00-00 |
Lamivudine and Zidovudine HUMAN PRESCRIPTION DRUG Details:
Item Description | Lamivudine and Zidovudine from Rebel Distributors Corp |
LABELER NAME: | Rebel Distributors Corp |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150; 300(mg/1; mg/1) |
START MARKETING DATE: | 2011-12-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 21695-996_d346d08d-ebb5-4500-923f-fe111f304876 |
PRODUCT NDC: | 21695-996 |
APPLICATION NUMBER: | ANDA079081 |
Other LAMIVUDINE; ZIDOVUDINE Pharmaceutical Manufacturers / Labelers: